Ratings CARE Ratings Limited

Equities

CARERATING

INE752H01013

Market Closed - NSE India S.E. Other stock markets 07:43:51 2024-05-15 am EDT			5-day change	1st Jan Change
1,096 ^INR	-0.68%		-4.25%	+15.23%

May. 10	Transcript : CARE Ratings Limited, Q4 2024 Earnings Call, May 10, 2024
May. 09	CARE Ratings Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Strengths

Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.21 times its estimated earnings per share for the ongoing year.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Professional Information Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CARE RATINGS LIMITED	+15.23%	395M		-
CRISIL LIMITED	+0.72%	3.79B		B+
ICRA LIMITED	-12.46%	584M		C
KOREA RATINGS CO., LTD.	+12.57%	281M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes